A new study has found a correlation between how hospitals are rated on Facebook’s five-star system and how well they performed on a widely-used measure of quality care.
Late in 2013, Facebook began providing organizations the option of allowing users to post ratings ranging from one to five stars on their official Facebook pages. The current study was designed to compare hospitals’ 30-day readmission rates with their Facebook ratings.
“We found that the hospitals in which patients were less likely to have unplanned readmissions within the 30 days after discharge had higher Facebook ratings than were those with higher readmission rates,” says lead author McKinley Glover, M.D., MHS, a clinical fellow in the Massachusetts General Hospital (MGH) Department of Radiology.
“Since user-generated social media feedback appears to be reflective of patient outcomes, hospitals and healthcare leaders should not underestimate social media’s value in developing quality improvement programs.”
As the use of social media has grown, consumers’ health care decisions may be influenced by information posted to social media sites by patients and others, the authors note. Several hospitals and healthcare organizations use social media for a variety of reasons, but there has been little investigation into whether hospitals ratings on social media accurately reflect patient satisfaction or the quality of care received.
For the study, the researchers analyzed data from Hospital Compare — a website sponsored by the Center for Medicare and Medicaid Services — on 30-day readmission rates for 4,800 U.S. hospitals. While more than 80 percent had rates within the expected national average range, seven percent had significantly lower-than-average readmission rates — a measure that reflects above-average care — and eight percent had rates that were significantly higher than average.
Low-readmission hospitals were more likely to have Facebook pages than were high-readmission hospitals — 93 percent versus 82 percent — and more than 80 percent of those in both groups with Facebook pages provided the five-star rating system. The findings showed that each one-star increase in a hospital’s Facebook rating was tied to a greater than five-fold increase in the likelihood that it would have a low, rather than a high readmission rate.
Other data available on hospital Facebook pages — such as the number of times users reported visiting the hospital, how long a hospital’s Facebook page had been available, and the number of Facebook ‘likes’ — did not make a difference in readmission rates.
“While we can’t say conclusively that social media ratings are fully representative of the actual quality of care, this research adds support to the idea that social media has quantitative value in assessing the areas of patient satisfaction — something we are hoping to study next — and other quality outcomes,” says Glover.
“Hospitals should be aware that social media ratings may influence patient perceptions of hospitals and potentially their healthcare choices. Hospitals and other healthcare organizations should also be aware of the potential message they send by not using social media.
“Members of the general public should be encouraged to provide accurate feedback on their healthcare experiences via social media, but should not rely solely on such ratings to make their health care decisions.”
Within 24 hours of Apple launching its platform for health research this month, tens of thousands of iPhone users had signed up to take part in five inaugural studies involving some of the US’s most respected medical institutions. A Harvard-affiliate
On l’appelle « ET-D5 » et elle pourrait bien révolutionner le milieu médical. Découverte par le Dr Aurélie Juhem, cette molécule est capable d’arrêter la prolifération d’une tumeur puis de détruire spécifiquement les vaisseaux formés pour l’alimenter. Testée avec succès sur des souris, cette molécule « miracle » sera expérimentée en 2016 sur des humains.
Apple, known for keeping its product developments under the strictest of lock-and-key, gave ABC News exclusive access into its top secret health and fitness lab, where only Apple employees became test subjects for the new Apple Watch.
Apple engineers, managers and developers have been secretly volunteering for the past year in this state-of-the-art lab to participate in rowing, running, yoga and many more fitness activities in order to collect data for the Apple Watch’s inner workings.
“[The employees] knew they were testing something, but they didn't know it was for the Apple Watch,” said Jeff Williams, Apple’s senior vice president of operations. “We hooked them up with all the masks and so forth, but we would put on an Apple Watch covered up.”
“Whether doctors choose to engage in social media or not, they cannot ignore its implications.” These were the emphatic words said by Pat Rich (@cmaer)
“Whether doctors choose to engage in social media or not, they cannot ignore its implications.” These were the emphatic words said by Pat Rich (@cmaer) during theHealthcare and Social Media Summit held last February 21, 2015.
Social media has changed the way we communicate and share information. Healthcare is a field fueled by accurate and reliable information. Social media is a good venue for patient education, patient support, health research, medical education and even fundraising for healthcare professionals (HCPs). It is likewise a good venue to obtain information, receive support and even track treatment progress for patients. It is inevitable that the synergy of healthcare and social media is happening.
As of January 2015, there are 40 million Filipinos who have active social media accounts each spending an average of 4 hours daily. That’s possibly 9.6 billion minutes spent on social media per day. If it takes less than a minute to like or share content, imagine how much information can be exchanged! It is mind-boggling!
HCPs are life-long learners who have the responsibility to update themselves on the latest practice guidelines in order to give the best patient care. Should this responsibility extend to learning how to communicate better and more efficiently with our community beyond our clinics and hospitals?
Let’s talk about why HCPs should engage in social media. Let’s explore the issues and challenges surrounding this and how we can address them. These are the topics we can discuss:
T1: Do healthcare professionals have the responsibility to engage in social media to communicate with their patients/community? Why or why not?
T2: What are the challenges of healthcare professionals in adopting social media in their practice? Why the hesitation?
T3: How do we address these issues/concerns? Should the initiative come from healthcare organizations or individual HCPs?
Let’s chat away on March 14, 2015, 9PM Manila time (8am EST). Do not forget to use the hashtag #HealthXPH. We are looking forward to all your tweets!
Reference: Global Web Index Q4 2014 and We Are Social SG
Le site 1001Pharmacies.com a réalisé une enquête du 1er janvier au 15 mars 2015 sur la relation des Français aux objets connectés, et plus particulièrement à la e-santé.
99% des personnes interrogées par 1001Pharmacies.com répondent être intéressées par les objets connectés. Ce chiffre est révélateur de l’appétence des français pour ce nouveaux produits.
« De plus en plus d’objets sont connectés à notre corps. Ces produits s’immiscent dans notre quotidien, avec pour objectif principal d’améliorer notre santé : pour garder la forme, pour améliorer ses performances, pour prévenir des maladies, pour diagnostiquer l’arrivée précoce de pathologies, etc. Pour l’instant, ces objets sont encore très peu utilisés, notamment à cause de leurs prix prohibitifs. Cependant, énormément de développements sont réalisés, et l’engouement qu’ils suscitent pousse à croire qu’ils deviendront rapidement indispensables aux utilisateurs. Mais que pensent vraiment les consommateurs de ces innovations technologiques ?» explique Cédric O’Neill, Pharmacien et co-fondateur de 1001Pharmacies.com.
It’s a question that comes up all the time in my discussions with senior industry executives – is social media actually worth the risk for a sector as heavily regulated as the pharmaceutical industry?
And while some may roll their eyes and denounce pharma as being backward for asking such a question, I don’t agree – it’s a great question and an extremely valid one. Every business decision has to consider risk versus benefit.
But here’s the problem with measuring that risk-benefit ratio: you need to consider the timeframe. It’s true for every decision ever made, no matter how big or small and it also applies to our personal lives. For example, there is a small but finite risk involved every time you travel in a car, train, boat or plane. If I considered that risk, versus the benefit of travelling to business meetings, over just a 24h timeframe I’d probably never bother (and also be perceived as being a little odd!). But at least some of those meetings will turn into mutually beneficial commercial relationships, so the benefit far outweighs the risk for me when you look at it over the longer-term. In fact, there is a longer-term risk, to my livelihood, from not travelling that is more worrying than the immediate one.
So if you’re just looking at the short-term risk-benefit ratio of anything you’re getting a distorted picture. This is exactly how I challenge people in pharma to look at it when they ask me about risk.
The benefits of social media engagement by pharmaceutical companies are very clear to me and, at a simple level, they are twofold.
Firstly, the relationships formed via social media engagement translate to the offline world. I know this because I’ve seen it happen many times with my business. Many of the healthcare influencers (patients / patient organisation leaders, industry executives, influential healthcare providers, media etc.) who I know on first-name terms initially met me via social media. When access to these people is often a major barrier for pharmaceutical companies the value of social media cannot be ignored.
Secondly, the kind of direct feedback you can receive via social media is fantastically useful – both directly online and, in line with the way it builds ‘real-world’ relationships outlined above, from subsequent offline conversations. In the information age, this kind of input that can only be obtained by being well-connected, can deliver a critical advantage. Social media listening is a start, but engaging delivers a whole new level of intelligence.
So that’s it – access to key customers and unique insights are the two main benefits for pharma using social media, in my view. Both have a major impact on the bottom line success of products.
And the immediate risks of engaging online? Most of them carry even bigger risks from not engaging in the longer-term.
For example, companies worry about picking up adverse events about their products, necessitating subsequent action. Yes – this might well happen, but what if people are having adverse events when using your products and you’re not picking them up? Where does that lead?
Or the notion that by taking part in social media activity, your critics might start to attack you. If you have such vocal critics the reality is they are already attacking you online and, unless you listen, you can’t take the necessary action to remedy it. So by not engaging, the reputational risk to your business – and associated commercial risk – is massive.
I could go on and on, but hopefully you get my point.
Online social engagement is here to stay. It’s only going to get more and more important as a conduit for connectivity and information sharing. So next time someone in pharma asks you if social media is worth the risk, ask them to cast their gaze a bit further down the line to a point when all their competitors are engaging online.
Is not engaging on social media then worth the risk?
Some reports show that up to nine out of 10 adverse reactions from drugs go unreported. In an effort to find those possible adverse drug reactions in medications, pharmaceutical companies are reportedly searching social media for a better chance at learning of potential adverse drug reactions. There are many potential adverse drug reactions that patients might not think of to report to their health care provider, according to The Pharmaceutical Journal.
“Adverse drug reactions (ADRs) are grossly under reported by everyone, including healthcare professionals, but particularly so by patients,” David Lewis, head of global safety at the Switzerland-based pharmaceutical company Novartis. Novartis is working on a three-year project called Web-RADR (Recognizing Adverse Drug Reactions) that will in part use social media information to determine if there are aftermarket adverse drug reactions in various medications. The program even uses the hashtag #pharmacovigilance.
Everyday, people take to social media and talk about their medication or their children’s medication. These scientists believe these posts have the potential to quickly warn pharmaceutical companies of potential drug reactions.
“Mining data from social media gives us a greater chance of capturing ADRs that a patient wouldn’t necessarily complain about to their doctor or nurse. Physicians are great at diagnosing illnesses and noting objective signs, but patients are great at reporting subjective reactions and feelings,” Lewis explained.”For example, a psychiatrist can’t see suicidal ideation as an ADR while a patient can describe it perfectly.”
Long before social media took on the form we see today, an American with HIV began taking antiretroviral medications, according to The Pharmaceutical Journal. On a patient web forum discussion board for the drug, back in 1997, the man wrote, “My belly button went from an inny to an outy.”
Before long, other patients reported the same adverse reaction to the antiretroviral drug on the discussion board. The adverse reaction was initially only reported through this old school form of social media. It became known as lipodystrophy syndrome. No one had even known it was a possible reaction that could come from the drug, because the drug’s safety trial only ran for 48 weeks, and this syndrome didn’t develop until after that 48 week cut-off point used by the drug company’s safety assessors. Therein lies the value of social media monitoring for adverse drug reactions, the pharmacovigilance supporters say.
Still, the idea of monitoring social media doesn’t sit well with some people, while others wonder whether a patient experiencing an adverse drug reaction who posts about it on social media should be contacted and informed of what they might be experiencing. “Would that be helpful or creepy,” the scientists wonder.
What do you think? How would you feel if someone contacted you and told you that, while searching social media for evidence of adverse drug reactions, they stumbled on your social media post?
A l'occasion de la Journée mondiale de la tuberculose, le Janssen Health Policy Centre a dévoilé mardi un tableau de bord numérique permettant de parcourir et de comparer les données sanitaires de 15 maladies parmi les plus répandues dans les 28 États membres de l'Union Européenne (UE), un outil d'analyse unique en son genre.
Video games can sometimes be associated with a sedentary lifestyle and unhealthy weight gain. A new study led by researchers at the George Washington University School of Public Health and Health Services (SPHHS) suggests that certain games could...
DirectHopital.com est le site dédié aux managers hospitaliers. Il traite d’actualités pratiques, de retour sur expérience et des nouvelles initiatives dans les domaines des RH, de la qualité / sécurité, des finances, des achats et de la logistique.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.